When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PGNX - Progenics +20% premarket on positive PyL data in prostate cancer
Progenics Pharmaceuticals Inc.
Progenics Pharmaceuticals (NASDAQ:PGNX) is up 20% premarket on announcing positive top line results from the Phase 3 CONDOR trial evaluating the diagnostic performance and clinical impact of PyL (18F-DCFPyL) in men with biochemical recurrence of prostate cancer.
More news on: Progenics Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,